https://drugnews.com.tw/articles/2026-10-06-novartis-growth-succession-capital-allocation-en.html Drugnews｜藥時事 en 2026-10-06T12:00:00.000Z Sales of a Star Heart Drug Have Halved. Can Novartis’s Next Medicines Take Over in Time? https://drugnews.com.tw/articles/2026-10-06-novartis-growth-succession-capital-allocation.html Drugnews｜藥時事 zh-tw 2026-10-06T12:00:00.000Z 明星心臟藥銷售減半，諾華的新藥接棒來得及嗎？ https://drugnews.com.tw/articles/2026-10-06-nobel-optogenetics-light-gated-channels-en.html Drugnews｜藥時事 en 2026-10-06T00:00:00.000Z A light switch for cells wins the Nobel Prize https://drugnews.com.tw/articles/2026-10-06-nobel-optogenetics-light-gated-channels.html Drugnews｜藥時事 zh-tw 2026-10-06T00:00:00.000Z 諾貝爾獎揭曉！科學家給細胞裝上光開關 https://drugnews.com.tw/articles/2026-10-05-cyclic-peptide-upstream-2026-en.html Drugnews｜藥時事 en 2026-10-05T00:00:00.000Z From a Daily Tablet to Factory Orders: Who Can Profit from Oral Cyclic Peptides? https://drugnews.com.tw/articles/2026-10-05-cyclic-peptide-upstream-2026.html Drugnews｜藥時事 zh-tw 2026-10-05T00:00:00.000Z 從每天一顆藥到工廠訂單：口服環肽的錢，誰賺得到？